Lupin Ltd.
NSE: LUPIN | BSE: 500257
₹2,285.50
₹-1.90
(-0.08%)
As on 20-May-2026IST
Market cap
₹1,04,401 Cr
Revenue (TTM)
₹27,958 Cr
P/E Ratio
19.6
P/B Ratio
4.7
Div. Yield
0.8 %
Quality Score
5/10
Growth Score
7/10
Valuation Score
6/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹5,333 Cr
-
ROE
21.1 %
-
ROCE
22 %
-
Industry P/E
31.68
-
EV/EBITDA
11.3
-
Debt to Equity
0.1
-
Book Value
₹491
-
EPS
₹126.1
-
Face value
2
-
Shares outstanding
457,215,863
10 Years Aggregate
CFO
₹19,351.73 Cr
EBITDA
₹29,810.84 Cr
Net Profit
₹10,621.71 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Lupin
| 8.3 | -1.7 | 2.5 | 12.6 | 43.4 | 13.6 | 3.3 |
|
BSE Healthcare
| 9.8 | 9.6 | 10.8 | 11.7 | 27.9 | 14.3 | 11.9 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Lupin
| -10.8 | 79.4 | 80.3 | -22.8 | -5.0 | 26.7 | -9.3 |
|
BSE Mid Cap
| 1.1 | 25.8 | 45.5 | 1.4 | 39.2 | 19.9 | -3.0 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Lupin
|
2,285.5 | 1,04,400.7 | 27,958.0 | 5,355.5 | 26.6 | 27.4 | 19.6 | 4.7 |
| 27,445.0 | 58,325.0 | 6,929.1 | 1,552.0 | 26.2 | 35.3 | 37.6 | 12.2 | |
| 3,188.8 | 39,860.7 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 37.7 | 8.8 | |
| 432.7 | 70,177.2 | 16,927.0 | 368.8 | 8.8 | -0.6 | 182 | 2.1 | |
| 1,399.5 | 1,13,051.7 | 28,162.6 | 3,869.8 | 16.6 | 12.1 | 29.1 | 3.3 | |
| 1,321.9 | 1,10,333.3 | 33,700.2 | 4,144.2 | 13.0 | 11.4 | 26.3 | 2.9 | |
| 2,346.8 | 39,769.8 | 3,821.7 | 1,036.0 | 32.5 | 51.4 | 38.4 | 17.5 | |
| 2,163.6 | 34,686.3 | 4,147.8 | 709.5 | 22.3 | 18.3 | 48.9 | 8.3 | |
| 2,583.9 | 1,06,668.9 | 14,277.6 | 1,926.4 | 19.1 | 12.8 | 55.8 | 6.5 | |
| 1,040.9 | 1,04,743.9 | 27,148.4 | 5,026.4 | 21.9 | 20.7 | 20.8 | 3.9 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Stock Rating update, March 22, 2024
2 min read•By Value Research
Companies that went from hero to zero
3 min read•By Hemkesh Khattar
5 min read•By Research Desk
1 min read•By Research Desk
2 min read•By Mohammed Ekramul Haque
About Lupin
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars,... over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women's health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India. Read more
-
Incorporated
1983
-
Chairman
Manju D Gupta
-
Managing Director
Nilesh Gupta
-
Group
Lupin
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Lupin
What is the current share price of Lupin Ltd Today?
The share price of Lupin Ltd is ₹2,285.50 (NSE) and ₹2,283.40 (BSE) as of 20-May-2026 IST. Lupin Ltd has given a return of 43.44% in the last 3 years.
What is the current PB & PE ratio of Lupin Ltd?
The P/E ratio of Lupin Ltd is 19.58 times as on 20-May-2026, a 38 discount to its peers’ median range of 31.68 times.
The P/B ratio of Lupin Ltd is 4.65 times as on 20-May-2026, a 0 premium to its peers’ median range of 4.65 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
28.20
|
5.40
|
|
2024
|
38.51
|
5.20
|
|
2023
|
68.54
|
2.39
|
|
2022
|
0.00
|
2.83
|
|
2021
|
38.08
|
3.40
|
What is the 52 Week High and Low of Lupin Ltd?
The 52-week high and low of Lupin Ltd are Rs 2,494.00 and Rs 1,836.80 as of 21-May-2026.
What is the market cap of Lupin Ltd?
Lupin Ltd has a market capitalisation of ₹ 1,04,401 Cr as on 20-May-2026. As per SEBI classification, it is a Mid Cap company.
Should I invest in Lupin Ltd?
Before investing in Lupin Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.